A step closer to eye drops for AMDMonday 19 November 2018
Last year, a team from the University of Birmingham invented a method of delivering macular degeneration drugs which are currently injected into the eyeball as eye drops. At the time they tested the drops on rats with significant success. Recently they have taken the tests a stage further by delivering the eye drops to larger mammals. The results give great cause for hope.
The latest tests involve rabbits and pigs, both of which have eyes which are more similar to human eyes. And in each case, the study showed that the eye drops can deliver a therapeutically effective dose of the drugs to the retina.
The team is working closely with a US company, Macgregan Inc, who own the pending patents for eye drops. It is hoped that clinical trials on humans could start as early as Spring 2019.
2.Investigative ophthalmology and visual science:
Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptide.
Labels:Sight News, AMD
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
- Diabetic retinopathy may increase chance of strokes
- Coronavirus – How your eyes can make it spread
- Gene editing could cure forms of blindness
- Lighting changes to save taxpayers £2.5 million
- Serious Readers win Platinum Service Award